NUVL: Nuvalent, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5,917.37
Enterprise Value ($M) 5,548.12
Book Value ($M) 1,121.13
Book Value / Share 17.09
Price / Book 5.28
NCAV ($M) 1,111.94
NCAV / Share 16.95
Price / NCAV 5.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.20
Return on Assets (ROA) -0.53
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 23.07
Current Ratio 23.07

Balance Sheet (mrq) ($M)
Current Assets 1,179.67
Assets 1,188.86
Liabilities 67.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13G/A Paradigm Biocapital Advisors LP 7.80 29.60
2 days ago 13G/A Perceptive Advisors Llc 4.60 2.10
8 days ago 13G BlackRock, Inc. 5.60 0.00
05-15 13G/A Flynn James E 33.99 0.40
03-29 13D/A Bain Capital Life Sciences Fund II, L.P. 4.10 0.00
02-14 13G/A Fairmount Funds Management LLC 3.40 -30.99
02-13 13G Vanguard Group Inc 5.72
02-09 13G/A Fmr Llc 14.94 14.51

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 207,070 682,830 30.33
2024-11-14 88,719 377,041 23.53
2024-11-13 77,422 436,053 17.76
2024-11-12 33,431 293,133 11.40
2024-11-11 21,250 238,788 8.90

(click for more detail)

Similar Companies
NEOG – Neogen Corporation NKTX – Nkarta, Inc.
NMRA – Neumora Therapeutics, Inc. NVAX – Novavax, Inc.
NXTC – NextCure, Inc.


Financial data and stock pages provided by
Fintel.io